Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
3.170
+0.040 (1.28%)
Nov 28, 2025, 4:00 PM EST - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $900.78 million as of November 28, 2025. Its market cap has increased by 2.57% in one year.
Market Cap
900.78M
Enterprise Value
602.30M
1-Year Change
2.57%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $900.78M, a decrease of -51.53%. That is a compound annual growth rate of -15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 888.02M | 25.14% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |